Apeiron Investment Group Ltd. 13D and 13G filings for Atai Life Sciences N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:29 pm Purchase |
2023-12-31 | 13G | Atai Life Sciences N.V. ATAI |
Apeiron Investment Group Ltd. | 33,885,999 20.100% |
1,214,297 (+3.72%) |
Filing |
| 2023-02-10 08:39 am Purchase |
2022-12-31 | 13G | Atai Life Sciences N.V. ATAI |
Apeiron Investment Group Ltd. | 32,671,702 19.400% |
612,198 (+1.91%) |
Filing |
| 2022-02-10 5:01 pm Purchase |
2021-12-31 | 13G | Atai Life Sciences N.V. ATAI |
Apeiron Investment Group Ltd. | 32,059,504 19.700% |
32,059,504 (New Position) |
Filing |